IL159670A0 - Use of il-18 binding protein in inflammations - Google Patents

Use of il-18 binding protein in inflammations

Info

Publication number
IL159670A0
IL159670A0 IL15967003A IL15967003A IL159670A0 IL 159670 A0 IL159670 A0 IL 159670A0 IL 15967003 A IL15967003 A IL 15967003A IL 15967003 A IL15967003 A IL 15967003A IL 159670 A0 IL159670 A0 IL 159670A0
Authority
IL
Israel
Prior art keywords
inflammations
binding protein
protein
binding
Prior art date
Application number
IL15967003A
Other languages
English (en)
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Priority to IL15967003A priority Critical patent/IL159670A0/xx
Publication of IL159670A0 publication Critical patent/IL159670A0/xx
Priority to EP04806701A priority patent/EP1699823A2/en
Priority to US10/584,805 priority patent/US20070264237A1/en
Priority to AU2004308763A priority patent/AU2004308763B2/en
Priority to CA002552155A priority patent/CA2552155A1/en
Priority to JP2006546476A priority patent/JP5420151B2/ja
Priority to PCT/IL2004/001170 priority patent/WO2005063290A2/en
Priority to IL176324A priority patent/IL176324A/en
Priority to NO20063458A priority patent/NO20063458L/no
Priority to US13/027,449 priority patent/US20110177065A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/545—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL15967003A 2003-12-31 2003-12-31 Use of il-18 binding protein in inflammations IL159670A0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
IL15967003A IL159670A0 (en) 2003-12-31 2003-12-31 Use of il-18 binding protein in inflammations
EP04806701A EP1699823A2 (en) 2003-12-31 2004-12-27 Use of il-18 binding protein in inflammations
US10/584,805 US20070264237A1 (en) 2003-12-31 2004-12-27 Use of Il-18 Binding Protein in Inflammations
AU2004308763A AU2004308763B2 (en) 2003-12-31 2004-12-27 Use of IL-18 binding protein in inflammations
CA002552155A CA2552155A1 (en) 2003-12-31 2004-12-27 Use of il-18 binding protein in inflammations
JP2006546476A JP5420151B2 (ja) 2003-12-31 2004-12-27 炎症におけるｉｌ−１８結合性タンパク質の使用
PCT/IL2004/001170 WO2005063290A2 (en) 2003-12-31 2004-12-27 Use of il-18 binding protein in inflammations
IL176324A IL176324A (en) 2003-12-31 2006-06-15 Protein IL-18 binder for the preparation of anti-inflammatory drugs
NO20063458A NO20063458L (no) 2003-12-31 2006-07-27 Anvendelse av IL-18-bindende protein ved betennelser
US13/027,449 US20110177065A1 (en) 2003-12-31 2011-02-15 Methods of treating/preventing inflammation using combination of il-1 antagonist and il-18 binding protein

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL15967003A IL159670A0 (en) 2003-12-31 2003-12-31 Use of il-18 binding protein in inflammations

Publications (1)

Publication Number Publication Date
IL159670A0 true IL159670A0 (en) 2004-06-01

Family

ID=33485385

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15967003A IL159670A0 (en) 2003-12-31 2003-12-31 Use of il-18 binding protein in inflammations
IL176324A IL176324A (en) 2003-12-31 2006-06-15 Protein IL-18 binder for the preparation of anti-inflammatory drugs

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL176324A IL176324A (en) 2003-12-31 2006-06-15 Protein IL-18 binder for the preparation of anti-inflammatory drugs

Country Status (8)

Country Link
US (2) US20070264237A1 (ja)
EP (1) EP1699823A2 (ja)
JP (1) JP5420151B2 (ja)
AU (1) AU2004308763B2 (ja)
CA (1) CA2552155A1 (ja)
IL (2) IL159670A0 (ja)
NO (1) NO20063458L (ja)
WO (1) WO2005063290A2 (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7968684B2 (en) 2003-11-12 2011-06-28 Abbott Laboratories IL-18 binding proteins
US7767206B2 (en) 2006-10-02 2010-08-03 Amgen Inc. Neutralizing determinants of IL-17 Receptor A and antibodies that bind thereto
WO2008131315A2 (en) 2007-04-20 2008-10-30 Amgen Inc. Jacquelinidentification and method for using the pre-ligand assembly domain of the il-17 receptor
TW201117824A (en) 2009-10-12 2011-06-01 Amgen Inc Use of IL-17 receptor a antigen binding proteins
PT3295957T (pt) 2010-01-15 2019-11-12 Kirin Amgen Inc Formulação de anticorpo anti il-17ra e regimes terapêuticos para o tratamento de psoríase
DE102011118024A1 (de) * 2011-08-01 2013-02-07 Technische Universität Dresden Inhibitor der Expression der Pro-Caspase 1
GB201400997D0 (en) * 2014-01-21 2014-03-05 Vib Vzw Targeting of interleukin-1 and -18 in treatment of septic shock
KR102511343B1 (ko) 2015-03-05 2023-03-17 에이비2 바이오 에스에이 염증성 질환에서 il-18 결합 단백질(ｉｌ-18ｂｐ) 및 항체
KR20220044057A (ko) * 2020-09-29 2022-04-06 주식회사 에이프릴바이오 인터루킨-18 결합 단백질 및 혈청 알부민에 대한 항원 결합 단편을 포함하는 융합 단백질, 및 이의 용도
WO2024029331A1 (ja) * 2022-07-30 2024-02-08 国立大学法人 東京医科歯科大学 関節疾患の治療及び／又は予防に用いるための医薬組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2288429C (en) * 1991-03-15 2006-04-25 Synergen, Inc. Pegylation of polypeptides
US7704944B2 (en) * 1997-08-14 2010-04-27 Yeda Research And Development Company Ltd. Interleukin-18 binding proteins, their preparation and use for the treatment of sepsis
IL121860A0 (en) * 1997-08-14 1998-02-22 Yeda Res & Dev Interleukin-18 binding proteins their preparation and use
WO2002032374A2 (en) * 2000-10-18 2002-04-25 Immunex Corporation Methods for treating il-18 mediated disorders
SI1487541T1 (sl) * 2002-03-22 2009-02-28 Serono Lab Uporaba inhibitorjev il-18 za zdravljenje in /alipreventivo bolezni perifernega oĺ˝ilja
US7005523B2 (en) * 2002-08-30 2006-02-28 Pfizer Inc. Cycloalkyl-[4-(trifluorophenyl)-oxazol-5yl]-triazolo-pyridines

Also Published As

Publication number Publication date
IL176324A0 (en) 2006-10-05
JP5420151B2 (ja) 2014-02-19
JP2007517020A (ja) 2007-06-28
NO20063458L (no) 2006-07-27
US20110177065A1 (en) 2011-07-21
AU2004308763A1 (en) 2005-07-14
AU2004308763B2 (en) 2011-06-16
WO2005063290A2 (en) 2005-07-14
CA2552155A1 (en) 2005-07-14
US20070264237A1 (en) 2007-11-15
WO2005063290A3 (en) 2005-10-13
IL176324A (en) 2013-08-29
EP1699823A2 (en) 2006-09-13

Similar Documents

Publication Publication Date Title
IL176324A0 (en) Il-18 binding protein in inflammations
AU2003227861A8 (en) Protein involved in cancer
GB0305267D0 (en) Proteins involved in apoptosis
GB0326192D0 (en) Proteins involved in signal transduction
GB0314894D0 (en) Improvements in and relating to antennas
GB0229875D0 (en) Protein involved in cancer
GB0305351D0 (en) Oligonucleotide binding protein in cancer
GB0305268D0 (en) Proteins involved in apoptosis
GB0305269D0 (en) Proteins involved in apoptosis
GB0305348D0 (en) Membrane-associated protein in cancer
GB0305342D0 (en) Protein folding in cancer
GB0308327D0 (en) A protein involved in cancer
GB0305387D0 (en) Protein stability and cancer
GB0321300D0 (en) Protein structure and uses thereof
GB0305353D0 (en) Apoptosis-related protein and cancer
GB0303632D0 (en) Secreted protein
GB0308610D0 (en) Secreted protein
GB0316704D0 (en) Protein
GB0305829D0 (en) Protein
GB0305450D0 (en) Protein
GB0303938D0 (en) Protein
GB0317013D0 (en) Protein
GB0316098D0 (en) Protein
GB0316562D0 (en) Protein
GB0321297D0 (en) Protein